Cargando…
Whole-body biodistribution and radiation dosimetry of [(18)F]PR04.MZ: a new PET radiotracer for clinical management of patients with movement disorders
PURPOSE: [(18)F]PR04.MZ is a new PET imaging agent for dopamine transporters, providing excellent image quality and allowing for the evaluation of patients with movement disorders such as Parkinson’s disease. The objective of this study was to evaluate the biodistribution and radiation dosimetry of...
Autores principales: | Lehnert, Wencke, Riss, Patrick J., Hurtado de Mendoza, Ana, Lopez, Sandra, Fernandez, Gonzalo, Ilheu, Marcelo, Amaral, Horacio, Kramer, Vasko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748605/ https://www.ncbi.nlm.nih.gov/pubmed/35006412 http://dx.doi.org/10.1186/s13550-021-00873-9 |
Ejemplares similares
-
[(18)F]PR04.MZ PET/CT Imaging for Evaluation of Nigrostriatal Neuron Integrity in Patients With Parkinson Disease
por: Juri, Carlos, et al.
Publicado: (2021) -
Biodistribution and dosimetry of a single dose of albumin-binding ligand [(177)Lu]Lu-PSMA-ALB-56 in patients with mCRPC
por: Kramer, Vasko, et al.
Publicado: (2020) -
Human Biodistribution and Radiation Dosimetry of the P-Glycoprotein Radiotracer [(11)C]Metoclopramide
por: Bauer, Martin, et al.
Publicado: (2021) -
Evaluation of Safety and Dosimetry of (177)Lu-DOTA-ZOL for Therapy of Bone Metastases
por: Fernández, René, et al.
Publicado: (2021) -
Human biodistribution and dosimetry of [(11)C]-UCB-J, a PET radiotracer for imaging synaptic density
por: Cawthorne, Christopher, et al.
Publicado: (2021)